Search Results

Benjamin Myers About Dr. Benjamin Myers Ben Myers is an assistant professor at the University of Utah School of Medicine in Salt Ben’s research focuses on Smoothened and other class F GPCRs which play essential roles in embryonic Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford Benjamin Myers on the web Website Twitter Pubmed University of Utah Dr.

<< Back to podcast list Strategic Partner(s) Murat Tunaboylu & Ben Holland About Murat Tunaboylu "Murat GPCR About Ben Holland "Ben gained his masters in Engineering Science from Oxford, taking a specialisation nearly 10 years, applying it to antibody generation, analysis, and property prediction since 2017" Ben

GPCR scientist Ben Clements shares how positive allosteric modulators could transform opioid therapy From Aspirations to Application: Ben’s Path into Science Ben shares his winding yet deliberate entry Allosteric Modulation: The New Frontier of GPCR Drug Discovery Ben reflects on the emerging potential About Ben Clements Dr. Ben Clements on the web University of Michigan X Google Scholar LinkedIn Unlock the Full Dr.

Brian Arey, Director of Mechanistic Pharmacology at Bristol-Myers Squibb, traces the origins of that Director of Mechanistic Pharmacology within the Discovery and Optimization organization at Bristol-Myers Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery and Optimization at Bristol-Myers

Following a post-doctoral period at Bristol Myers Squibb in Princeton USA, Andrew returned to the UK

pharmacologist and physiologist with over 25 years of pharmaceutical research experience at Bristol-Myers Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery and Optimization at Bristol-Myers

Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers

Abishek Iyer, CEO Ashta Therapeutics Before working with Yamina, we had solid internal momentum but needed